nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—Isopropamide—Propantheline—pancreatitis	0.785	1	CrCrCtD
Methadone—Mydriasis—Propantheline—pancreatitis	0.00705	0.0546	CcSEcCtD
Methadone—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00448	0.0347	CcSEcCtD
Methadone—Respiratory depression—Hyoscyamine—pancreatitis	0.00382	0.0296	CcSEcCtD
Methadone—Pulmonary function test decreased—Hyoscyamine—pancreatitis	0.00382	0.0296	CcSEcCtD
Methadone—Ventricular fibrillation—Hyoscyamine—pancreatitis	0.00376	0.0291	CcSEcCtD
Methadone—Mydriasis—Hyoscyamine—pancreatitis	0.00361	0.028	CcSEcCtD
Methadone—Extrasystoles—Hyoscyamine—pancreatitis	0.00342	0.0265	CcSEcCtD
Methadone—Drowsiness—Propantheline—pancreatitis	0.00314	0.0244	CcSEcCtD
Methadone—Muscle twitching—Hyoscyamine—pancreatitis	0.00293	0.0227	CcSEcCtD
Methadone—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.00288	0.0223	CcSEcCtD
Methadone—Dermatitis contact—Hyoscyamine—pancreatitis	0.00284	0.022	CcSEcCtD
Methadone—Flushing—Propantheline—pancreatitis	0.00262	0.0203	CcSEcCtD
Methadone—Pulmonary oedema—Hyoscyamine—pancreatitis	0.00256	0.0198	CcSEcCtD
Methadone—Swelling—Hyoscyamine—pancreatitis	0.00237	0.0183	CcSEcCtD
Methadone—Disorientation—Hyoscyamine—pancreatitis	0.00234	0.0181	CcSEcCtD
Methadone—Palpitations—Propantheline—pancreatitis	0.00217	0.0168	CcSEcCtD
Methadone—Dry mouth—Propantheline—pancreatitis	0.00205	0.0159	CcSEcCtD
Methadone—Confusional state—Propantheline—pancreatitis	0.00202	0.0157	CcSEcCtD
Methadone—Anaphylactic shock—Propantheline—pancreatitis	0.00201	0.0155	CcSEcCtD
Methadone—Irritability—Hyoscyamine—pancreatitis	0.00199	0.0154	CcSEcCtD
Methadone—Urinary retention—Hyoscyamine—pancreatitis	0.00199	0.0154	CcSEcCtD
Methadone—Cardiac arrest—Hyoscyamine—pancreatitis	0.00199	0.0154	CcSEcCtD
Methadone—Tachycardia—Propantheline—pancreatitis	0.00196	0.0152	CcSEcCtD
Methadone—Hypokalaemia—Hyoscyamine—pancreatitis	0.0019	0.0147	CcSEcCtD
Methadone—Insomnia—Propantheline—pancreatitis	0.00181	0.0141	CcSEcCtD
Methadone—Somnolence—Propantheline—pancreatitis	0.00178	0.0138	CcSEcCtD
Methadone—Constipation—Propantheline—pancreatitis	0.00172	0.0133	CcSEcCtD
Methadone—Feeling abnormal—Propantheline—pancreatitis	0.00165	0.0128	CcSEcCtD
Methadone—Drowsiness—Hyoscyamine—pancreatitis	0.00161	0.0125	CcSEcCtD
Methadone—Urticaria—Propantheline—pancreatitis	0.00159	0.0123	CcSEcCtD
Methadone—Sweating—Hyoscyamine—pancreatitis	0.00154	0.012	CcSEcCtD
Methadone—Hypersensitivity—Propantheline—pancreatitis	0.00148	0.0114	CcSEcCtD
Methadone—Bradycardia—Hyoscyamine—pancreatitis	0.00147	0.0114	CcSEcCtD
Methadone—Asthenia—Propantheline—pancreatitis	0.00144	0.0111	CcSEcCtD
Methadone—Hallucination—Hyoscyamine—pancreatitis	0.00144	0.0111	CcSEcCtD
Methadone—Flushing—Hyoscyamine—pancreatitis	0.00134	0.0104	CcSEcCtD
Methadone—Dizziness—Propantheline—pancreatitis	0.00133	0.0103	CcSEcCtD
Methadone—Arrhythmia—Hyoscyamine—pancreatitis	0.00129	0.01	CcSEcCtD
Methadone—Vomiting—Propantheline—pancreatitis	0.00128	0.00988	CcSEcCtD
Methadone—Rash—Propantheline—pancreatitis	0.00126	0.0098	CcSEcCtD
Methadone—Dermatitis—Propantheline—pancreatitis	0.00126	0.00979	CcSEcCtD
Methadone—Erythema—Hyoscyamine—pancreatitis	0.00126	0.00975	CcSEcCtD
Methadone—Headache—Propantheline—pancreatitis	0.00126	0.00973	CcSEcCtD
Methadone—Nausea—Propantheline—pancreatitis	0.00119	0.00923	CcSEcCtD
Methadone—Agitation—Hyoscyamine—pancreatitis	0.00116	0.00896	CcSEcCtD
Methadone—Vertigo—Hyoscyamine—pancreatitis	0.00113	0.00876	CcSEcCtD
Methadone—Syncope—Hyoscyamine—pancreatitis	0.00113	0.00874	CcSEcCtD
Methadone—Palpitations—Hyoscyamine—pancreatitis	0.00111	0.00861	CcSEcCtD
Methadone—Loss of consciousness—Hyoscyamine—pancreatitis	0.00111	0.00857	CcSEcCtD
Methadone—Convulsion—Hyoscyamine—pancreatitis	0.00109	0.00844	CcSEcCtD
Methadone—Anxiety—Hyoscyamine—pancreatitis	0.00107	0.00827	CcSEcCtD
Methadone—Dry mouth—Hyoscyamine—pancreatitis	0.00105	0.00811	CcSEcCtD
Methadone—Confusional state—Hyoscyamine—pancreatitis	0.00104	0.00802	CcSEcCtD
Methadone—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00103	0.00795	CcSEcCtD
Methadone—Oedema—Hyoscyamine—pancreatitis	0.00103	0.00795	CcSEcCtD
Methadone—Shock—Hyoscyamine—pancreatitis	0.00101	0.00783	CcSEcCtD
Methadone—Tachycardia—Hyoscyamine—pancreatitis	0.001	0.00776	CcSEcCtD
Methadone—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000993	0.00769	CcSEcCtD
Methadone—Hypotension—Hyoscyamine—pancreatitis	0.000959	0.00743	CcSEcCtD
Methadone—Insomnia—Hyoscyamine—pancreatitis	0.000929	0.00719	CcSEcCtD
Methadone—Somnolence—Hyoscyamine—pancreatitis	0.000913	0.00707	CcSEcCtD
Methadone—Pain—Hyoscyamine—pancreatitis	0.000878	0.0068	CcSEcCtD
Methadone—Constipation—Hyoscyamine—pancreatitis	0.000878	0.0068	CcSEcCtD
Methadone—Feeling abnormal—Hyoscyamine—pancreatitis	0.000846	0.00655	CcSEcCtD
Methadone—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00084	0.0065	CcSEcCtD
Methadone—Urticaria—Hyoscyamine—pancreatitis	0.000816	0.00632	CcSEcCtD
Methadone—Abdominal pain—Hyoscyamine—pancreatitis	0.000812	0.00629	CcSEcCtD
Methadone—Body temperature increased—Hyoscyamine—pancreatitis	0.000812	0.00629	CcSEcCtD
Methadone—Hypersensitivity—Hyoscyamine—pancreatitis	0.000756	0.00586	CcSEcCtD
Methadone—Asthenia—Hyoscyamine—pancreatitis	0.000737	0.00571	CcSEcCtD
Methadone—Pruritus—Hyoscyamine—pancreatitis	0.000726	0.00563	CcSEcCtD
Methadone—Diarrhoea—Hyoscyamine—pancreatitis	0.000703	0.00544	CcSEcCtD
Methadone—Dizziness—Hyoscyamine—pancreatitis	0.000679	0.00526	CcSEcCtD
Methadone—Vomiting—Hyoscyamine—pancreatitis	0.000653	0.00506	CcSEcCtD
Methadone—Rash—Hyoscyamine—pancreatitis	0.000647	0.00502	CcSEcCtD
Methadone—Dermatitis—Hyoscyamine—pancreatitis	0.000647	0.00501	CcSEcCtD
Methadone—Headache—Hyoscyamine—pancreatitis	0.000643	0.00498	CcSEcCtD
Methadone—Nausea—Hyoscyamine—pancreatitis	0.00061	0.00472	CcSEcCtD
Methadone—Oxaprozin—PTGS2—pancreatitis	0.000177	0.269	CrCbGaD
Methadone—Phenylbutazone—PTGS2—pancreatitis	0.000117	0.178	CrCbGaD
Methadone—Atomoxetine—HTR2A—pancreatitis	0.000103	0.156	CrCbGaD
Methadone—Propiomazine—HTR2A—pancreatitis	9.65e-05	0.146	CrCbGaD
Methadone—Trimipramine—HTR2A—pancreatitis	8.44e-05	0.128	CrCbGaD
Methadone—Promethazine—HTR2A—pancreatitis	8.13e-05	0.123	CrCbGaD
Methadone—CYP2C19—Metabolism—PRSS1—pancreatitis	2.45e-05	0.000287	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ALDH2—pancreatitis	2.45e-05	0.000287	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GCG—pancreatitis	2.44e-05	0.000285	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADH4—pancreatitis	2.4e-05	0.000281	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SST—pancreatitis	2.4e-05	0.000281	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PRSS1—pancreatitis	2.39e-05	0.00028	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FGA—pancreatitis	2.38e-05	0.000279	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HTR2A—pancreatitis	2.38e-05	0.000279	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADH4—pancreatitis	2.38e-05	0.000279	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—DUSP6—pancreatitis	2.38e-05	0.000278	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KNG1—pancreatitis	2.34e-05	0.000274	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—XDH—pancreatitis	2.34e-05	0.000274	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PNLIP—pancreatitis	2.32e-05	0.000272	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PRSS3—pancreatitis	2.32e-05	0.000272	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCL2—pancreatitis	2.28e-05	0.000267	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	2.28e-05	0.000267	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PNLIP—pancreatitis	2.27e-05	0.000266	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PRSS3—pancreatitis	2.27e-05	0.000266	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PRSS1—pancreatitis	2.25e-05	0.000264	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—BDKRB2—pancreatitis	2.25e-05	0.000264	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PRSS1—pancreatitis	2.24e-05	0.000262	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTHLH—pancreatitis	2.22e-05	0.00026	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SMO—pancreatitis	2.22e-05	0.00026	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CNR1—pancreatitis	2.21e-05	0.000259	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—LPL—pancreatitis	2.19e-05	0.000257	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—FDX1—pancreatitis	2.19e-05	0.000256	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ADH1B—pancreatitis	2.18e-05	0.000255	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FGB—pancreatitis	2.17e-05	0.000254	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	2.16e-05	0.000254	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HTR2A—pancreatitis	2.16e-05	0.000253	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PDGFA—pancreatitis	2.15e-05	0.000252	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GCG—pancreatitis	2.14e-05	0.000251	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PRSS3—pancreatitis	2.14e-05	0.00025	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PNLIP—pancreatitis	2.14e-05	0.00025	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GCG—pancreatitis	2.14e-05	0.00025	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PNLIP—pancreatitis	2.12e-05	0.000248	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PRSS3—pancreatitis	2.12e-05	0.000248	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PPP3CA—pancreatitis	2.11e-05	0.000248	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—XDH—pancreatitis	2.08e-05	0.000244	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PLA2G1B—pancreatitis	2.05e-05	0.00024	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KNG1—pancreatitis	2.05e-05	0.00024	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.05e-05	0.00024	CbGpPWpGaD
Methadone—ABCB1—Metabolism—XDH—pancreatitis	2.03e-05	0.000238	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADH4—pancreatitis	2.03e-05	0.000238	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SST—pancreatitis	2.03e-05	0.000237	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—DUSP6—pancreatitis	2.01e-05	0.000235	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PLA2G1B—pancreatitis	2.01e-05	0.000235	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL2—pancreatitis	2e-05	0.000234	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCL8—pancreatitis	1.99e-05	0.000233	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—A2M—pancreatitis	1.98e-05	0.000232	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL5—pancreatitis	1.96e-05	0.000229	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CTRB2—pancreatitis	1.95e-05	0.000228	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ADH1B—pancreatitis	1.94e-05	0.000228	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—A2M—pancreatitis	1.94e-05	0.000227	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—XDH—pancreatitis	1.92e-05	0.000225	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—LPL—pancreatitis	1.91e-05	0.000224	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PRSS1—pancreatitis	1.91e-05	0.000224	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—BDKRB2—pancreatitis	1.91e-05	0.000223	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—XDH—pancreatitis	1.9e-05	0.000223	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ADH1B—pancreatitis	1.9e-05	0.000222	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PDGFA—pancreatitis	1.89e-05	0.000221	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CNR1—pancreatitis	1.87e-05	0.000219	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GCG—pancreatitis	1.86e-05	0.000218	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.83e-05	0.000214	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALDH2—pancreatitis	1.81e-05	0.000212	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SPP1—pancreatitis	1.81e-05	0.000212	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PRSS3—pancreatitis	1.81e-05	0.000212	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PNLIP—pancreatitis	1.81e-05	0.000212	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GCG—pancreatitis	1.81e-05	0.000212	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCL8—pancreatitis	1.8e-05	0.000211	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADH1B—pancreatitis	1.79e-05	0.000209	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	1.78e-05	0.000208	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADH1B—pancreatitis	1.77e-05	0.000208	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALDH2—pancreatitis	1.77e-05	0.000208	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCL8—pancreatitis	1.74e-05	0.000204	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PLA2G1B—pancreatitis	1.74e-05	0.000204	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KNG1—pancreatitis	1.73e-05	0.000203	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HTR2A—pancreatitis	1.72e-05	0.000202	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL5—pancreatitis	1.71e-05	0.000201	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL2—pancreatitis	1.69e-05	0.000198	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—FDX1—pancreatitis	1.69e-05	0.000198	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—LPL—pancreatitis	1.68e-05	0.000197	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—A2M—pancreatitis	1.68e-05	0.000197	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—LPL—pancreatitis	1.68e-05	0.000196	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.67e-05	0.000195	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	1.66e-05	0.000194	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	1.64e-05	0.000193	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—XDH—pancreatitis	1.62e-05	0.00019	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—LEP—pancreatitis	1.6e-05	0.000188	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PPARG—pancreatitis	1.6e-05	0.000188	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PDGFA—pancreatitis	1.59e-05	0.000187	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SPP1—pancreatitis	1.59e-05	0.000186	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL8—pancreatitis	1.58e-05	0.000185	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—INS—pancreatitis	1.57e-05	0.000184	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADH4—pancreatitis	1.57e-05	0.000184	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PLA2G1B—pancreatitis	1.55e-05	0.000182	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALDH2—pancreatitis	1.53e-05	0.00018	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADH1B—pancreatitis	1.51e-05	0.000177	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PLA2G1B—pancreatitis	1.51e-05	0.000177	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HTR2A—pancreatitis	1.51e-05	0.000177	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—A2M—pancreatitis	1.5e-05	0.000175	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.5e-05	0.000175	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PRSS1—pancreatitis	1.47e-05	0.000173	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL8—pancreatitis	1.47e-05	0.000172	CbGpPWpGaD
Methadone—ABCB1—Metabolism—A2M—pancreatitis	1.46e-05	0.000171	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—LPL—pancreatitis	1.46e-05	0.000171	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL5—pancreatitis	1.45e-05	0.00017	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—NRAS—pancreatitis	1.45e-05	0.000169	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ALB—pancreatitis	1.44e-05	0.000169	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PLA2G1B—pancreatitis	1.43e-05	0.000167	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.43e-05	0.000167	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—LPL—pancreatitis	1.42e-05	0.000166	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PLA2G1B—pancreatitis	1.41e-05	0.000166	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—LEP—pancreatitis	1.41e-05	0.000165	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PRSS3—pancreatitis	1.4e-05	0.000164	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PNLIP—pancreatitis	1.4e-05	0.000164	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—A2M—pancreatitis	1.38e-05	0.000161	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GCG—pancreatitis	1.37e-05	0.000161	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALDH2—pancreatitis	1.37e-05	0.00016	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—INS—pancreatitis	1.37e-05	0.00016	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—A2M—pancreatitis	1.37e-05	0.00016	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL2—pancreatitis	1.35e-05	0.000158	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.35e-05	0.000158	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GCG—pancreatitis	1.34e-05	0.000157	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SPP1—pancreatitis	1.34e-05	0.000157	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALDH2—pancreatitis	1.34e-05	0.000157	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL8—pancreatitis	1.34e-05	0.000157	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.34e-05	0.000156	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HTR2A—pancreatitis	1.28e-05	0.00015	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—NRAS—pancreatitis	1.27e-05	0.000149	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALDH2—pancreatitis	1.26e-05	0.000148	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—pancreatitis	1.26e-05	0.000148	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—XDH—pancreatitis	1.25e-05	0.000147	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALDH2—pancreatitis	1.25e-05	0.000146	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—KRAS—pancreatitis	1.25e-05	0.000146	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PPARG—pancreatitis	1.23e-05	0.000144	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.22e-05	0.000143	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PLA2G1B—pancreatitis	1.21e-05	0.000142	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—INS—pancreatitis	1.2e-05	0.000141	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.2e-05	0.000141	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—INS—pancreatitis	1.2e-05	0.000141	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—LEP—pancreatitis	1.19e-05	0.000139	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL2—pancreatitis	1.18e-05	0.000138	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.18e-05	0.000138	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADH1B—pancreatitis	1.17e-05	0.000137	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—A2M—pancreatitis	1.17e-05	0.000137	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GCG—pancreatitis	1.16e-05	0.000136	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MDM2—pancreatitis	1.14e-05	0.000133	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.11e-05	0.000131	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ALB—pancreatitis	1.1e-05	0.000129	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.09e-05	0.000128	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—KRAS—pancreatitis	1.09e-05	0.000128	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—LPL—pancreatitis	1.08e-05	0.000126	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—NRAS—pancreatitis	1.07e-05	0.000126	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALDH2—pancreatitis	1.07e-05	0.000125	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL8—pancreatitis	1.07e-05	0.000125	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PPARG—pancreatitis	1.06e-05	0.000125	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HRAS—pancreatitis	1.06e-05	0.000124	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—LPL—pancreatitis	1.05e-05	0.000123	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.05e-05	0.000123	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—INS—pancreatitis	1.04e-05	0.000122	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.04e-05	0.000122	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GCG—pancreatitis	1.04e-05	0.000122	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CASP3—pancreatitis	1.02e-05	0.000119	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—INS—pancreatitis	1.01e-05	0.000119	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GCG—pancreatitis	1.01e-05	0.000119	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL6—pancreatitis	1.01e-05	0.000119	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MDM2—pancreatitis	9.99e-06	0.000117	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL2—pancreatitis	9.98e-06	0.000117	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—pancreatitis	9.64e-06	0.000113	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	9.58e-06	0.000112	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ALB—pancreatitis	9.57e-06	0.000112	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GCG—pancreatitis	9.55e-06	0.000112	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GCG—pancreatitis	9.47e-06	0.000111	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	9.36e-06	0.00011	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—pancreatitis	9.34e-06	0.000109	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PLA2G1B—pancreatitis	9.32e-06	0.000109	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRAS—pancreatitis	9.28e-06	0.000109	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—KRAS—pancreatitis	9.23e-06	0.000108	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—LPL—pancreatitis	9.13e-06	0.000107	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—A2M—pancreatitis	9.01e-06	0.000105	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CASP3—pancreatitis	8.94e-06	0.000105	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—pancreatitis	8.88e-06	0.000104	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NRAS—pancreatitis	8.55e-06	0.0001	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MDM2—pancreatitis	8.44e-06	9.89e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—pancreatitis	8.37e-06	9.81e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDH2—pancreatitis	8.24e-06	9.65e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	8.19e-06	9.59e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—LPL—pancreatitis	8.15e-06	9.54e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GCG—pancreatitis	8.09e-06	9.47e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—LPL—pancreatitis	7.95e-06	9.31e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—pancreatitis	7.94e-06	9.3e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—pancreatitis	7.89e-06	9.25e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARG—pancreatitis	7.87e-06	9.22e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—pancreatitis	7.84e-06	9.19e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—INS—pancreatitis	7.72e-06	9.04e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARG—pancreatitis	7.69e-06	9.01e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—pancreatitis	7.56e-06	8.85e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—INS—pancreatitis	7.54e-06	8.84e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—pancreatitis	7.51e-06	8.79e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NRAS—pancreatitis	7.49e-06	8.78e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—LPL—pancreatitis	7.49e-06	8.78e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—LPL—pancreatitis	7.43e-06	8.7e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—pancreatitis	7.35e-06	8.62e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—pancreatitis	7.08e-06	8.29e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—pancreatitis	6.96e-06	8.16e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—pancreatitis	6.92e-06	8.1e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARG—pancreatitis	6.66e-06	7.8e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—INS—pancreatitis	6.54e-06	7.66e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—pancreatitis	6.45e-06	7.55e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—LPL—pancreatitis	6.35e-06	7.43e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NRAS—pancreatitis	6.33e-06	7.42e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—pancreatitis	6.25e-06	7.32e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCG—pancreatitis	6.24e-06	7.31e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—pancreatitis	6.19e-06	7.25e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—pancreatitis	6.05e-06	7.09e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—pancreatitis	5.99e-06	7.02e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—pancreatitis	5.98e-06	7.01e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARG—pancreatitis	5.95e-06	6.97e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—pancreatitis	5.88e-06	6.89e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—INS—pancreatitis	5.83e-06	6.83e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARG—pancreatitis	5.8e-06	6.8e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—INS—pancreatitis	5.69e-06	6.67e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—pancreatitis	5.48e-06	6.42e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARG—pancreatitis	5.47e-06	6.41e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—pancreatitis	5.45e-06	6.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARG—pancreatitis	5.42e-06	6.35e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—INS—pancreatitis	5.37e-06	6.28e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—pancreatitis	5.35e-06	6.26e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—INS—pancreatitis	5.32e-06	6.23e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—pancreatitis	5.25e-06	6.15e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—pancreatitis	5.24e-06	6.14e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—pancreatitis	5.22e-06	6.11e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—pancreatitis	4.92e-06	5.76e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LPL—pancreatitis	4.9e-06	5.74e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—pancreatitis	4.88e-06	5.71e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—pancreatitis	4.68e-06	5.48e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARG—pancreatitis	4.63e-06	5.43e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—pancreatitis	4.63e-06	5.43e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—pancreatitis	4.57e-06	5.35e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—INS—pancreatitis	4.54e-06	5.32e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—pancreatitis	4.43e-06	5.19e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—pancreatitis	4.3e-06	5.04e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—pancreatitis	4.27e-06	5e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—pancreatitis	4.17e-06	4.88e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—pancreatitis	3.65e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARG—pancreatitis	3.58e-06	4.19e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—INS—pancreatitis	3.51e-06	4.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—pancreatitis	3.22e-06	3.77e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—pancreatitis	2.81e-06	3.3e-05	CbGpPWpGaD
